Disease | multiple system atrophy |
Comorbidity | C0030567|parkinson\'s disease |
Sentences | 7 |
PubMedID- 25745454 | Another study found significantly increased levels of nf-l and nf-h in parkinson's disease with multiple system atrophy and various protein labeling[78]. |
PubMedID- 23815045 | Objectives: we sought to compare the laryngeal symptoms of parkinson's disease (pd) with those of multiple system atrophy (msa), a parkinson-plus syndrome; to review the differences in surgical management of upper airway dysfunction between patients with pd and those with msa; and to present a treatment algorithm for management of upper airway disorders in patients with pd and msa. |
PubMedID- 22102521 | There was a trend for greater asymmetry of striatal binding in multiple system atrophy compared with parkinson's disease (23% +/- 15% vs 10.5% +/- 7%, respectively; p = .071), with 3 multiple system atrophy patients showing more asymmetry of striatal binding than any parkinson's disease patient. |
PubMedID- 23525968 | multiple system atrophy (msa) together with parkinson's disease belongs to a diverse group of neurodegenerative conditions termed alpha-synucleinopathies. |
PubMedID- 24355363 | Sensorimotor gating deficits in multiple system atrophy: comparison with parkinson's disease and idiopathic rem sleep behavior disorder. |
PubMedID- 22888453 | The α-synuclein dysfunction is the critical pathogenic event in parkinson's disease that leads to multiple system atrophy and dementia with lewy bodies [167, 169]. |
PubMedID- 24940065 | The diagnoses were: parkinson's disease with dementia, multiple system atrophy parkinsonian type, multiple system atrophy cerebellar type, progressive supranuclear palsy, corticobasal degeneration, lewy body dementia, and frontotemporal dementia with parkinsonism. |
Page: 1